General Information
Gasherbrum Obesity 09
A Phase 2a, Randomized, Double-Blind, Placebo-controlled, Study of the Safety, Tolerability, and Efficacy of Increasing Optimal Doses of GSBR-1290 in Participants Living with Obesity (Body Mass Index >30kg/m) or Overweight (Body Mass Index >27kg/m) with at Least One Weight-related Cormorbidity.
| Protocol | GSBR-1290-09 |
|---|---|
| Identifier | |
| UID | c3a2d7c1-ffaa-4d59-a3bd-9d278eb05e35 |
| Status | Follow-up |
| Phase | 2a |
| Category | Obesity / Adult |
| Launch Year | 2024 |
| NCT Number | - |
| Created | 2024-10-16 17:36 |
| Last Updated | 2025-02-10 16:31 |
Description
No description provided.
Comment
No comment.
Target Dates
| Name | Date | Required |
|---|---|---|
| Enrollment Closed | 2025-02-10 | No |
| Enrollment Open | 2025-01-07 | No |
| First Patient First Visit | No | |
| Site Initiation Mtg. | 2024-12-19 | No |
| PI Meeting Start | No | |
| PI Meeting End | No | |
| PI Meeting Arrival | No | |
| PI Meeting Departure | No | |
| Closeout Date | No | |
| Final PatientVisit | No | |
| PreStudy Selection Visit | No | |
| Target Date 12 | No | |
| Target Date 13 | No | |
| Target Date 14 | No |
Leadership
| Role | Staff | Login | Required |
|---|---|---|---|
| Principal | Mohseni, Rizwana | RMohseni | No |
| Recruiter | Gomez, Kathie | KGomez | No |
| Coordinator | Gallardo, Michael | MGallardo | No |
| Regulatory | Ramirez, Claudia | CRamirez | No |
Custom Fields
No custom fields.
Sponsor & Organization
| Sponsor | Gasherbrum Bio, Inc. |
|---|---|
| Division | Gasherbrum Bio, Inc. |
| Team | Gasherbrum Bio, Inc. |
| Managing Site | Catalina Research Institute, LLC |
| Organization |
Contacts
| IRB Ref | |
|---|---|
| CRO | Parexel International, LLC |
| CRO Ref | |
| Correspondence | 0 |
Opportunity
| Probability | 0 |
|---|---|
| Comment | |
| Status Color | PaleGoldenrod |
| Currency | - |
